NKG2D blockade prevents autoimmune diabetes in NOD mice

Immunity

Volumn 20, Issue 6, 2004, Pages 757-767

  Ogasawara, Kouetsu ^a   Hamerman, Jessica A ^a   Ehrlich, Lauren R ^a   Bour Jordan, Helene ^b   Santamaria, Pere ^c   Bluestone, Jeffrey A ^b   Lanier, Lewis L ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALGARY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

LIGAND; MONOCLONAL ANTIBODY; RECEPTOR PROTEIN; RETINOIC ACID;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOIMMUNE DISEASE; DISEASE COURSE; INSULIN DEPENDENT DIABETES MELLITUS; MOUSE; MOUSE STRAIN; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROPHYLAXIS; PROTEIN FAMILY;

ADOPTIVE TRANSFER; ANIMALS; ANTIBODIES; CD8-POSITIVE T-LYMPHOCYTES; CELL DIVISION; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 1; FLOW CYTOMETRY; ISLETS OF LANGERHANS; MEMBRANE PROTEINS; MICE; MICE, INBRED NOD; MICE, SCID; MICE, TRANSGENIC; RECEPTORS, IMMUNOLOGIC; RNA, MESSENGER;

EID: 2942546678     PISSN: 10747613     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.immuni.2004.05.008     Document Type: Article

References (34)

1. Amrani A., Verdaguer J., Serra P., Tafuro S., Tan R., Santamaria P. Progression of autoimmune diabetes driven by avidity maturation of a T-cell population. Nature. 406:2000;739-742
2. Ansari M.J., Salama A.D., Chitnis T., Smith R.N., Yagita H., Akiba H., Yamazaki T., Azuma M., Iwai H., Khoury S.J., et al. The programmed death-1 (PD-1) pathway regulates autoimmune diabetes in nonobese diabetic (NOD) mice. J. Exp. Med. 198:2003;63-69
3. Bach J.F. Insulin-dependent diabetes mellitus as an autoimmune disease. Endocr. Rev. 15:1994;516-542
4. Balasa B., Krahl T., Patstone G., Lee J., Tisch R., McDevitt H.O., Sarvetnick N. CD40 ligand-CD40 interactions are necessary for the initiation of insulitis and diabetes in nonobese diabetic mice. J. Immunol. 159:1997;4620-4627
5. Castano L., Eisenbarth G.S. Type-I diabetes. a chronic autoimmune disease of human, mouse, and rat Annu. Rev. Immunol. 8:1990;647-679
6. Cerwenka A., Lanier L.L. Ligands for natural killer cell receptors. redundancy or specificity Immunol. Rev. 181:2001;158-169
7. Cerwenka A., Carter L.L., Reome J.B., Swain S.L., Dutton R.W. In vivo persistence of CD8 polarized T cell subsets producing type 1 or type 2 cytokines. J. Immunol. 161:1998;97-105
8. Cerwenka A., Bakker A.B., McClanahan T., Wagner J., Wu J., Phillips J.H., Lanier L.L. Retinoic acid early inducible genes define a ligand family for the activating NKG2D receptor in mice. Immunity. 12:2000;721-727
9. Delovitch T.L., Singh B. The nonobese diabetic mouse as a model of autoimmune diabetes. immune dysregulation gets the NOD Immunity. 7:1997;727-738
10. Diefenbach A., Jamieson A.M., Liu S.D., Shastri N., Raulet D.H. Ligands for the murine NKG2D receptor. expression by tumor cells and activation of NK cells and macrophages Nat. Immunol. 1:2000;119-126
11. Diefenbach A., Tomasello E., Lucas M., Jamieson A.M., Hsia J.K., Vivier E., Raulet D.H. Selective associations with signaling proteins determine stimulatory versus costimulatory activity of NKG2D. Nat. Immunol. 3:2002;1142-1149
12. DiLorenzo T.P., Graser R.T., Ono T., Christianson G.J., Chapman H.D., Roopenian D.C., Nathenson S.G., Serreze D.V. Major histocompatibility complex class I-restricted T cells are required for all but the end stages of diabetes development in nonobese diabetic mice and use a prevalent T cell receptor alpha chain gene rearrangement. Proc. Natl. Acad. Sci. USA. 95:1998;12538-12543
13. Groh V., Bruhl A., El-Gabalawy H., Nelson J.L., Spies T. Stimulation of T cell autoreactivity by anomalous expression of NKG2D and its MIC ligands in rheumatoid arthritis. Proc. Natl. Acad. Sci. USA. 100:2003;9452-9457
14. Guo Z., Mital D., Shen J., Chong A.S., Tian Y., Foster P., Sankary H., McChesney L., Jensik S.C., Williams J.W. Immunosuppression preventing concordant xenogeneic islet graft rejection is not sufficient to prevent recurrence of autoimmune diabetes in nonobese diabetic mice. Transplantation. 65:1998;1310-1314
15. Jamieson A.M., Diefenbach A., McMahon C.W., Xiong N., Carlyle J.R., Raulet D.H. The role of the NKG2D immunoreceptor in immune cell activation and natural killing. Immunity. 17:2002;19-29
16. Katz J., Benoist C., Mathis D. Major histocompatibility complex class I molecules are required for the development of insulitis in non-obese diabetic mice. Eur. J. Immunol. 23:1993;3358-3360
17. Lenschow D.J., Herold K.C., Rhee L., Patel B., Koons A., Qin H.Y., Fuchs E., Singh B., Thompson C.B., Bluestone J.A. CD28/B7 regulation of Th1 and Th2 subsets in the development of autoimmune diabetes. Immunity. 5:1996;285-293
18. Liblau R.S., Wong F.S., Mars L.T., Santamaria P. Autoreactive CD8 T cells in organ-specific autoimmunity. emerging targets for therapeutic intervention Immunity. 17:2002;1-6
19. Lieberman S.M., Evans A.M., Han B., Takaki T., Vinnitskaya Y., Caldwell J.A., Serreze D.V., Shabanowitz J., Hunt D.F., Nathenson S.G., et al. Identification of the beta cell antigen targeted by a prevalent population of pathogenic CD8+ T cells in autoimmune diabetes. Proc. Natl. Acad. Sci. USA. 100:2003;8384-8388
20. Lodoen M., Ogasawara K., Hamerman J.A., Arase H., Houchins J.P., Mocarski E.S., Lanier L.L. NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules. J. Exp. Med. 197:2003;1245-1253
21. Mathis D., Vence L., Benoist C. beta-Cell death during progression to diabetes. Nature. 414:2001;792-798
22. Nagata M., Santamaria P., Kawamura T., Utsugi T., Yoon J.W. Evidence for the role of CD8+ cytotoxic T cells in the destruction of pancreatic beta-cells in nonobese diabetic mice. J. Immunol. 152:1994;2042-2050
23. Ogasawara K., Hamerman J.A., Hsin H., Chikuma S., Bour-Jordan H., Chen T., Pertel T., Carnaud C., Bluestone J.A., Lanier L.L. Impairment of NK cell function by NKG2D modulation in NOD mice. Immunity. 18:2003;41-51
24. Roberts A.I., Lee L., Schwarz E., Groh V., Spies T., Ebert E.C., Jabri B. NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenvironment. J. Immunol. 167:2001;5527-5530
25. Salomon B., Bluestone J.A. Complexities of CD28/B7. CTLA-4 costimulatory pathways in autoimmunity and transplantation Annu. Rev. Immunol. 19:2001;225-252
26. Serra P., Amrani A., Han B., Yamanouchi J., Thiessen S.J., Santamaria P. RAG-dependent peripheral T cell receptor diversification in CD8+ T lymphocytes. Proc. Natl. Acad. Sci. USA. 99:2002;15566-15571
27. Serreze D.V., Leiter E.H. Genes and cellular requirements for autoimmune diabetes susceptibility in nonobese diabetic mice. Curr. Dir. Autoimmun. 4:2001;31-67
28. Serreze D.V., Leiter E.H., Christianson G.J., Greiner D., Roopenian D.C. Major histocompatibility complex class I-deficient NOD-B2mnull mice are diabetes and insulitis resistant. Diabetes. 43:1994;505-509
29. Tisch R., McDevitt H. Insulin-dependent diabetes mellitus. Cell. 85:1996;291-297
30. Trudeau J.D., Kelly-Smith C., Verchere C.B., Elliott J.F., Dutz J.P., Finegood D.T., Santamaria P., Tan R. Prediction of spontaneous autoimmune diabetes in NOD mice by quantification of autoreactive T cells in peripheral blood. J. Clin. Invest. 111:2003;217-223
31. Verdaguer J., Schmidt D., Amrani A., Anderson B., Averill N., Santamaria P. Spontaneous autoimmune diabetes in monoclonal T cell nonobese diabetic mice. J. Exp. Med. 186:1997;1663-1676
32. Wicker L.S., Leiter E.H., Todd J.A., Renjilian R.J., Peterson E., Fischer P.A., Podolin P.L., Zijlstra M., Jaenisch R., Peterson L.B. Beta 2-microglobulin-deficient NOD mice do not develop insulitis or diabetes. Diabetes. 43:1994;500-504
33. Wicker L.S., Todd J.A., Peterson L.B. Genetic control of autoimmune diabetes in the NOD mouse. Annu. Rev. Immunol. 13:1995;179-200
34. Wu J., Song Y., Bakker A.B., Bauer S., Spies T., Lanier L.L., Phillips J.H. An activating immunoreceptor complex formed by NKG2D and DAP10. Science. 285:1999;730-732